{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/12583"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/12583","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Safety aspects of prolonged chronic low-frequency transcranial magnetic stimulation: evaluation of reactive gliosis and histopathology","abstract":"Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive technique used to modulate cortical excitability of excitatory and inhibitory neural networks, the effects of which often outlast initial application. Although rTMS is used both clinically and experimentally, the potential deleterious consequences, especially when delivered chronically, remain unclear and its safety is still largely unknown. Our current study evaluates the effects of prolonged chronic low-frequency rTMS on the immunoreactivity of glial fibrillary acidic protein (GFAP) and ionized calcium binding adaptor molecule 1 (Iba1) for the assessment of glial activation in a feline model of rTMS facilitated visuospatial neglect recovery. Conscious subjects were treated daily with 1 Hz rTMS (60% machine output) for 20' over the course of 14 weeks. In comparison with control animals receiving sham treatment, quantitative analysis of protein concentrations by optical density revealed no significant alterations in localized GFAP levels following chronic 1Hz rTMS. Iba1 visualization was unattained resulting presumably from inadequacies with species cross-reactivity of primary antibodies. Visual assessment of morphology showed no alterations typically associated with histopathology or indications of glial proliferation. These results suggest that extensive low-frequency rTMS does not induce reactive gliosis or gross histopathology, affording continued evidence for the safety of rTMS.","abstract_html":"Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive technique used to modulate cortical excitability of excitatory and inhibitory neural networks, the effects of which often outlast initial application. Although rTMS is used both clinically and experimentally, the potential deleterious consequences, especially when delivered chronically, remain unclear and its safety is still largely unknown. Our current study evaluates the effects of prolonged chronic low-frequency rTMS on the immunoreactivity of glial fibrillary acidic protein (GFAP) and ionized calcium binding adaptor molecule 1 (Iba1) for the assessment of glial activation in a feline model of rTMS facilitated visuospatial neglect recovery. Conscious subjects were treated daily with 1 Hz rTMS (60% machine output) for 20&#x27; over the course of 14 weeks. In comparison with control animals receiving sham treatment, quantitative analysis of protein concentrations by optical density revealed no significant alterations in localized GFAP levels following chronic 1Hz rTMS. Iba1 visualization was unattained resulting presumably from inadequacies with species cross-reactivity of primary antibodies. Visual assessment of morphology showed no alterations typically associated with histopathology or indications of glial proliferation. These results suggest that extensive low-frequency rTMS does not induce reactive gliosis or gross histopathology, affording continued evidence for the safety of rTMS.","abstract_has_math":false,"creators":["Paskus, Jeremiah David"],"institution":"Boston University","degree_name":"Master of Arts","degree_level":"masters","degree_discipline":"Anatomy and Neurobiology","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2012,"date_issued":"2012","date_published":"2012","updated_at":"2026-11-18T20:15:54Z","subjects":[],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["(ALMA)contemp"],"render_values":[{"text":"(ALMA)contemp","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/12583","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/12583","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F12583","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Paskus, Jeremiah David"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2015-08-05T01:18:35Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2015-08-05T01:18:35Z"]},{"key":"dc:date.issued","label":"Date","values":["2012"]},{"key":"dc:date.submitted","label":"Dc Date Submitted","values":["2012"]},{"key":"dc:publisher","label":"Institution","values":["Boston University"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Anatomy and Neurobiology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Arts"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["(ALMA)contemp"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/12583"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (M.A.)--Boston University PLEASE NOTE: Boston University Libraries did not receive an Authorization To Manage form for this thesis or dissertation. It is therefore not openly accessible, though it may be available by request. If you are the author or principal advisor of this work and would like to request open access for it, please contact us at open-help@bu.edu. Thank you."]},{"key":"dc:description.abstract","label":"Abstract","values":["Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive technique used to modulate cortical excitability of excitatory and inhibitory neural networks, the effects of which often outlast initial application. Although rTMS is used both clinically and experimentally, the potential deleterious consequences, especially when delivered chronically, remain unclear and its safety is still largely unknown. Our current study evaluates the effects of prolonged chronic low-frequency rTMS on the immunoreactivity of glial fibrillary acidic protein (GFAP) and ionized calcium binding adaptor molecule 1 (Iba1) for the assessment of glial activation in a feline model of rTMS facilitated visuospatial neglect recovery. Conscious subjects were treated daily with 1 Hz rTMS (60% machine output) for 20' over the course of 14 weeks. In comparison with control animals receiving sham treatment, quantitative analysis of protein concentrations by optical density revealed no significant alterations in localized GFAP levels following chronic 1Hz rTMS. Iba1 visualization was unattained resulting presumably from inadequacies with species cross-reactivity of primary antibodies. Visual assessment of morphology showed no alterations typically associated with histopathology or indications of glial proliferation. These results suggest that extensive low-frequency rTMS does not induce reactive gliosis or gross histopathology, affording continued evidence for the safety of rTMS."]},{"key":"dc:title","label":"Title","values":["Safety aspects of prolonged chronic low-frequency transcranial magnetic stimulation: evaluation of reactive gliosis and histopathology"]}]}],"canonical_facts":{"dc:creator":["Paskus, Jeremiah David"],"dc:date.accessioned":["2015-08-05T01:18:35Z"],"dc:date.available":["2015-08-05T01:18:35Z"],"dc:date.issued":["2012"],"dc:date.submitted":["2012"],"dc:description":["Thesis (M.A.)--Boston University PLEASE NOTE: Boston University Libraries did not receive an Authorization To Manage form for this thesis or dissertation. It is therefore not openly accessible, though it may be available by request. If you are the author or principal advisor of this work and would like to request open access for it, please contact us at open-help@bu.edu. Thank you."],"dc:description.abstract":["Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive technique used to modulate cortical excitability of excitatory and inhibitory neural networks, the effects of which often outlast initial application. Although rTMS is used both clinically and experimentally, the potential deleterious consequences, especially when delivered chronically, remain unclear and its safety is still largely unknown. Our current study evaluates the effects of prolonged chronic low-frequency rTMS on the immunoreactivity of glial fibrillary acidic protein (GFAP) and ionized calcium binding adaptor molecule 1 (Iba1) for the assessment of glial activation in a feline model of rTMS facilitated visuospatial neglect recovery. Conscious subjects were treated daily with 1 Hz rTMS (60% machine output) for 20' over the course of 14 weeks. In comparison with control animals receiving sham treatment, quantitative analysis of protein concentrations by optical density revealed no significant alterations in localized GFAP levels following chronic 1Hz rTMS. Iba1 visualization was unattained resulting presumably from inadequacies with species cross-reactivity of primary antibodies. Visual assessment of morphology showed no alterations typically associated with histopathology or indications of glial proliferation. These results suggest that extensive low-frequency rTMS does not induce reactive gliosis or gross histopathology, affording continued evidence for the safety of rTMS."],"dc:identifier.other":["(ALMA)contemp"],"dc:identifier.uri":["https://hdl.handle.net/2144/12583"],"dc:language.iso":["en_US"],"dc:publisher":["Boston University"],"dc:title":["Safety aspects of prolonged chronic low-frequency transcranial magnetic stimulation: evaluation of reactive gliosis and histopathology"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Anatomy and Neurobiology"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Arts"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T20:15:54Z"}